Bath & Body Works (NYSE:BBWI) Given New $42.00 Price Target at The Goldman Sachs Group

Bath & Body Works (NYSE:BBWI - Get Free Report) had its target price decreased by The Goldman Sachs Group from $49.00 to $42.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. The Goldman Sachs Group's target price would suggest a potential upside of 41.84% from the company's current price.

Several other analysts have also recently weighed in on the company. Raymond James dropped their price objective on Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating for the company in a report on Thursday, April 17th. Argus reissued a "hold" rating on shares of Bath & Body Works in a research note on Friday, January 10th. Wells Fargo & Company upgraded shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and increased their price objective for the company from $42.00 to $48.00 in a report on Friday, January 10th. Cowen reaffirmed a "buy" rating on shares of Bath & Body Works in a report on Thursday, February 27th. Finally, Barclays dropped their target price on shares of Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating for the company in a research report on Monday, March 3rd. Four research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, Bath & Body Works presently has an average rating of "Moderate Buy" and an average target price of $42.69.

Bath & Body Works Price Performance

Shares of BBWI stock traded down $0.14 during trading hours on Tuesday, reaching $29.61. 3,024,953 shares of the company were exchanged, compared to its average volume of 4,790,661. Bath & Body Works has a fifty-two week low of $24.96 and a fifty-two week high of $52.99. The stock's fifty day moving average is $31.33 and its two-hundred day moving average is $33.84. The company has a market cap of $6.34 billion, a price-to-earnings ratio of 7.22, a P/E/G ratio of 0.92 and a beta of 1.69.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.04 by $0.05. The firm had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. On average, research analysts anticipate that Bath & Body Works will post 3.3 earnings per share for the current year.

Bath & Body Works declared that its Board of Directors has authorized a stock repurchase program on Thursday, February 27th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to purchase up to 6.4% of its shares through open market purchases. Shares buyback programs are often a sign that the company's leadership believes its shares are undervalued.

Institutional Trading of Bath & Body Works

A number of hedge funds and other institutional investors have recently made changes to their positions in BBWI. Golden State Wealth Management LLC acquired a new stake in Bath & Body Works in the 4th quarter valued at $26,000. SRS Capital Advisors Inc. increased its position in shares of Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after acquiring an additional 329 shares during the last quarter. UMB Bank n.a. raised its holdings in Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock worth $35,000 after acquiring an additional 335 shares in the last quarter. Lindbrook Capital LLC boosted its position in Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after purchasing an additional 431 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in Bath & Body Works in the third quarter valued at approximately $39,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.